the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer
the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer
Recruiting · NCT07380646 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer | Cytopenia, Hemic and Lymphatic Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, agranulocytosis, breast cancer, breast disorder, breast neoplasm, hematologic disorder, leukocyte disorder, leukopenia, neoplasm, neutropenia, skin disorder | Recruiting | Phase 2 | 2026-09-28 | NCT07380646 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 561 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Breast surgery department | Hangzhou | China | 1 |